Synergistic Provoking of Pyroptosis and STING Pathway by Multifunctional Manganese‐Polydopamine Nano‐Immunomodulator for Enhanced Renal Cell Carcinoma Immunotherapy
Advanced Healthcare Materials · 2025-06 · 14 (16)
DOI: 10.1002/adhm.202500141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 20.05.2025. Verfasst von Yufei Du und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Basic …. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Manganese, Pyroptosis, Kidney Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Science and Technology Planning Project of Guangdong Province.
Abstract (Originalsprache)
Manganese ions are known to enhance anti‐tumor immunity by activating the cGAS‐STING signaling pathway. However, precise modulation of the tumor microenvironment using manganese ions remains a challenge. Dopamine, with its controlled release properties within the tumor microenvironment, offers significant potential for precision drug delivery systems. Metastatic renal cell carcinoma (RCC), being refractory to conventional treatments, necessitates innovative therapeutic approaches. In this study, a multifunctional manganese‐polydopamine nano‐immunomodulator coated with hyaluronic acid (PDA‐Mn‐HA NPs) is developed. These nanoparticles selectively bind to CD44 molecules, which are highly expressed in tumor‐associated macrophages and RCC cells, and release manganese ions in a tumor microenvironment‐responsive manner. Treatment with PDA‐Mn‐HA NPs effectively induces macrophage M1 polarization, triggers the production of pro‐inflammatory cytokines and chemokines. Transcriptomic analysis reveals that PDA‐Mn‐HA NPs polarize and activate macrophages through the reactive oxygen species(ROS)‐STING‐p38/MAPK signaling pathway. Additionally, PDA‐Mn‐HA NPs induce ROS‐caspase‐3/GSDME‐dependent pyroptosis in RCC cells via a Fenton‐like reaction. In RCC mouse models, PDA‐Mn‐HA NPs remodel the macrophage‐mediated immune microenvironment, enhance immune cell infiltration, and significantly suppress tumor growth. In conclusion, multifunctional PDA‐Mn‐HA NPs demonstrate translational potential by addressing the limitations of precision manganese delivery and achieving synergistic targeting of macrophages and tumor cells, offering a promising therapeutic strategy for RCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Basic and Translational Medical Research Center, Sun Yat-sen Memorial Hospit…
- School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
- School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, China.
- Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, China.
ORCID-Profile: Yufei Du, Yiming Zhou, Yue Pan
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Science and Technology Planning Project of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Du, Y., Mai, Y., Liu, Z., Lin, G., Luo, S., Guo, C., Qiao, G., Wang, L., Zhu, S., Zhou, Y., & Pan, Y. (2025). Synergistic Provoking of Pyroptosis and STING Pathway by Multifunctional Manganese‐Polydopamine Nano‐Immunomodulator for Enhanced Renal Cell Carcinoma Immunotherapy. Advanced Healthcare Materials, 14(16). https://doi.org/10.1002/adhm.202500141
Vancouver
Du Y, Mai Y, Liu Z, Lin G, Luo S, Guo C, et al. Synergistic Provoking of Pyroptosis and STING Pathway by Multifunctional Manganese‐Polydopamine Nano‐Immunomodulator for Enhanced Renal Cell Carcinoma Immunotherapy. Advanced Healthcare Materials. 2025;14(16). doi:10.1002/adhm.202500141
BibTeX
@article{Du2025,
author = {Du, Yufei and Mai, Yiyin and Liu, Zhiwen and Lin, Guanghui and Luo, Siweier and Guo, Chipeng and Qiao, Ge and Wang, Le and Zhu, Shuang and Zhou, Yiming and Pan, Yue},
title = {Synergistic Provoking of Pyroptosis and STING Pathway by Multifunctional Manganese‐Polydopamine Nano‐Immunomodulator for Enhanced Renal Cell Carcinoma Immunotherapy},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {16},
doi = {10.1002/adhm.202500141}
}
EUVIMED